Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Nanoparticle transport across the blood brain barrier.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
American Society for Neurochemistry Annual Meeting
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
Boxed warning of HBV risk added to Rituxan, Arezerra
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
Opinion: Sex inclusion in basic research drives discovery.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
199 Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
Berlex continues legal challenge to FDA over MS drug.

Pages